Dividend Assets Capital’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-4,000
| Closed | -$42K | – | 566 |
|
2023
Q1 | $42K | Hold |
4,000
| – | – | 0.01% | 301 |
|
2022
Q4 | $42K | Hold |
4,000
| – | – | 0.01% | 301 |
|
2022
Q3 | $18K | Hold |
4,000
| – | – | ﹤0.01% | 387 |
|
2022
Q2 | $16K | Hold |
4,000
| – | – | ﹤0.01% | 420 |
|
2022
Q1 | $29K | Hold |
4,000
| – | – | 0.01% | 348 |
|
2021
Q4 | $22K | Hold |
4,000
| – | – | ﹤0.01% | 374 |
|
2021
Q3 | $26K | Sell |
4,000
-1,000
| -20% | -$6.5K | 0.01% | 352 |
|
2021
Q2 | $42K | Hold |
5,000
| – | – | 0.01% | 320 |
|
2021
Q1 | $52K | Buy |
5,000
+1,000
| +25% | +$10.4K | 0.01% | 298 |
|
2020
Q4 | $68K | Buy |
+4,000
| New | +$68K | 0.01% | 244 |
|